Skip to content
The Times USA
Menu
  • ABOUT
  • CONTACT
  • LIFESTYLE
  • NATIONAL NEWS
  • BUSINESS
  • INTERNATIONAL NEWS
  • TECHNOLOGY
  • PRICE OF BUSINESS SHOW AUDIOS
Menu

U.S. CRISPR-Cas9 Patent was Granted by the University of California

Posted on August 27, 2019August 20, 2019 by admin

Today, the U.S. Patent and Trademark Office has awarded a new patent (U.S. 10,385,360) to the University of California (UC), University of Vienna, and Dr. Emmanuelle Charpentier covering nucleic acid molecules encoding single-molecule guide RNAs, as well as CRISPR-Cas9 compositions comprising single-molecule guide RNAs or nucleic acid molecules encoding single-molecule guide RNAs.

Over the past six months, UC’s U.S. CRISPR-Cas9 portfolio has sharply increased, and to date includes 11 separate patents for methods and compositions related to the gene-editing technology. Looking ahead, UC anticipates at least six additional related patents issuing in the near future, bringing UC’s total portfolio to 17 patents and spanning various compositions and methods including targeting and editing genes in any setting, such as within plant, animal, and human cells. The portfolio also includes patents related to the modulation of transcription.

“The USPTO has continually acknowledged the Doudna-Charpentier team’s groundbreaking work,” said Eldora L. Ellison, Ph.D., lead patent strategist on CRISPR-Cas9 matters for UC and a Director at Sterne, Kessler, Goldstein & Fox. “True to UC’s mission as a leading public university, the patent granted today and others in its CRISPR-Cas9 portfolio will be applied for the betterment of society.”

The Doudna-Charpentier team that invented the CRISPR-Cas9 DNA-targeting technology included Jennifer Doudna and Martin Jinek at the University of California, Berkeley; Emmanuelle Charpentier (then of Umea University); and Krzysztof Chylinski at the University of Vienna. The methods covered by today’s patent, as well as the other methods claimed in UC’s previously issued patents and those set to issue, were included among the CRISPR-Cas9 gene editing technology work disclosed first by the Doudna-Charpentier team in its May 25, 2012 priority patent application.

Additional CRISPR-Cas9 patents in this team’s portfolio include 10,000,772; 10,113,167; 10,227,611; 10,266,850; 10,301,651; 10,308,961; 10,337,029; 10,351,878; 10,358,658; and 10,358,659. These patents remain unchallenged and are not a part of the PTAB’s recently declared interference between 10 UC patent applications and multiple previously issued Broad Institute patents and one application, which jeopardizes essentially all of the Broad’s CRISPR patents involving eukaryotic cells.

International patent offices have also recognized the pioneering innovations of the Doudna-Charpentier team, in addition to the 11 patents granted in the U.S. so far. The European Patent Office (representing more than 30 countries), as well as patent offices in the United Kingdom, China, Japan, Australia, New Zealand, Mexico, and other countries, have issued patents for the use of CRISPR-Cas9 gene editing in all types of cells.

University of California has a long-standing commitment to develop and apply its patented technologies, including CRISPR-Cas9, for the betterment of humankind. Consistent with its open-licensing policies, UC allows nonprofit institutions, including academic institutions, to use the technology for non-commercial educational and research purposes.

In the case of CRISPR-Cas9, UC has also encouraged widespread commercialization of the technology through its exclusive license with Caribou Biosciences, Inc. of Berkeley, California. Caribou has sublicensed this patent family to numerous companies worldwide, including Intellia Therapeutics, Inc. for certain human therapeutic applications. Additionally, Dr. Charpentier has licensed the technology to CRISPR Therapeutics AG and ERS Genomics Limited.

You Might Also Like...

  • DK Patent Files for Improved Camera Photography

    More and more vehicles are leaving the production line with features such as adaptive cruise…

  • DK Patent Files for Improved Camera Photography

    More and more vehicles are leaving the production line with features such as adaptive cruise…

  • Canadian Consumers will See a Jump in Food Prices

    The average Canadian family is expected to spend $411 more on food in 2019 than…

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

VIDEO: This Week’s Best of our Network

https://www.youtube.com/watch?v=O47JYKa1Foo

GDPR Compliance

USABR does not collect data on its visitors.  For more information visit: https://www.usabusinessradio.com/contact-us/

Contact

Contact articles@usabusinessradio.net for more information on articles on this site. BMuyco@usabusinessradio.net for all other information.

Recent Articles

  • Why Trump’s 2025 Birthright Citizenship Order Faces Legal Hurdles
  • AI Is Driving a Necessary Shift in Content Strategies
  • How To Get a Gig Without Losing Your Mind (or Your Voice)
  • RFJTV Becomes a Slamer and Sound Engineer With AI
  • Unexpected Services Locksmiths Offer That Might Surprise You

Also in TTUSA

  • Why Should You Hire An Executive Assistant?
  • Remembering the Late, Great, Tony Bennett
  • The Fastest Growing and Quickest Declining Airports
  • Misconceptions About Enterprise Search
  • Disruption and Innovation in the Healthcare Space

RSS The Daily Blaze

  • What’s in Trump’s “Big, Beautiful Budget Bill” in the U.S. House?
  • Texas Voucher Law May Worsen Inequality and Inflate Costs
  • Former Congressman: Dislike the Politician, Not Supporters
  • When LTCI Policyholders Make Poor Decisions
  • Confident Voices, Lasting Impact

RSS USA Business Radio

  • Once You’ve Met Your Elimination Period, You’re Done… Even if You Pause Using Your LTCI Benefits
  • Qatar’s Gift of Luxury Jet to U.S. Sparks Ethics and Security Concerns
  • Your Business Partner Just Went Rogue—What Now?
  • Professional Athlete to Professional Educator
  • How a Later-Life Career Sparked Luxury Adventures for Travelers

RSS USA Daily Times

  • Caregivers: Smart Advocacy by Understanding Research Costs
  • Estate Planning Considerations for Exiting Business Owners
  • Quantum Awareness Unveiled: Living in Alignment With Universal Energy
  • How Weight Loss Drugs Work
  • Bridging the Divide: Pursuing Racial Unity in the Body of Christ

RSS USA Daily Chronicles.

  • Once You’ve Met Your Elimination Period, You’re Done… Even if You Pause Using Your LTCI Benefits
  • Qatar’s Gift of Luxury Jet to U.S. Sparks Ethics and Security Concerns
  • Your Business Partner Just Went Rogue—What Now?
  • Professional Athlete to Professional Educator
  • How a Later-Life Career Sparked Luxury Adventures for Travelers

RSS Price of Business

RSS US Daily Review

  • The Real Reason for James Carville’s Attack of David Hogg’s Plans to Save the Democratic Party
  • American Cardinal Robert Prevost Elected Pope Leo XIV in Historic First
  • The Ultimate Guide to Personalized (Vanity) License Plates in the US
  • Trump’s AI Pope Meme Sparks Outcry Among MAGA Supporters Following Pope Francis’ Death
  • Burn Bright, Not Out

PoB Digital Network

US Daily Review

USA Business Radio

USA Daily Chronicles

USA Daily Times

The Daily Blaze

The Times USA

Price of Business

© 2025 The Times USA | Powered by Superbs Personal Blog theme